Urologic Diseases D014570

Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urologic Diseases

Diseases [C] » Urogenital Diseases [C12] » Urologic Diseases

Description

Pathological processes of the URINARY TRACT in both males and females.   MeSH

Subtype Terms (8)

Kidney Diseases
435 drugs (264 approved, 171 experimental)

Ureteral Diseases
40 drugs (31 approved, 9 experimental)

Urethral Diseases
18 drugs (15 approved, 3 experimental)

Urinary Bladder Diseases
51 drugs (32 approved, 19 experimental)

Urinary Tract Infections
200 drugs (110 approved, 90 experimental)

Urination Disorders
55 drugs (40 approved, 15 experimental)

Urolithiasis
29 drugs (21 approved, 8 experimental)

Urologic Neoplasms
33 drugs (24 approved, 9 experimental)


Phase 1 Indicated Drugs (3)


Organization Involved with Phase 4 Indications (3)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.